Bluebird Bio reported $1.45B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acceleron Pharma XLRN:US $ 836.05M 39.74M
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Amgen AMGN:US $ 59773M 2766M
Applied Genetic Technologies AGTC:US $ 129.67M 57.7M
Arrowhead Research ARWR:US $ 734.93M 21.87M
Avrobio Inc AVRO:US $ 238.1M 7.82M
Biogen BIIB:US $ 24470.4M 615.7M
Biomarin Pharmaceutical BMRN:US $ 5898.5M 93.44M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Dicerna Pharmaceuticals DRNA:US $ 838.49M 155.08M
Gilead Sciences GILD:US $ 67984M 492M
Immunogen IMGN:US $ 301.45M 44.52M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Moderna Inc MRNA:US 16.15B 3.46B
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Novartis NOVN:VX SF 124015M 2263M
Ptc Therapeutics PTCT:US $ 2058.67M 53.27M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M
Vertex Pharmaceuticals VRTX:US $ 12221.69M 106.63M
YTE INCY:US $ 3904.62M 243.19M